arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

CONMED Corp

CNMD
$49.08 ▼ -0.69 (-1.38%) at close
Healthcare ·Electromedical & Electrotherapeutic Apparatus ·USElectromedical & Electrotherapeutic Apparatus
68 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
61
Health
Fair
Neutral
auto_awesome

Analytical Summary

CONMED Corp shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $1.5B
Dividend Yield
Revenue Growth 0.3%
Op. Margin 10.6%
ROIC 2.6%
FCF / Share None
Trailing P/E 63.7x
Price / Book 1.4x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$343.49M
— +0.3%
Net Income Profit after all expenses
$23.07M
↑ +7.7%
Operating Margin Operating profit as % of sales
10.6%
↑ +8.0% 50th
FCF / Share Free cash flow per share
$1.57
↑ +28.5%
Long-Term Debt Long-term obligations
$794.17M
↓ -1.9%

Health Breakdown

Profitability
53
Returns
53
Financial Health
67
Cash Quality
92

Dividend History

Dividend / share · sourced from SEC filings
$0.60 Latest / share
-25.0% YoY
-2.6% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 18 years · 68 quarters